- Home
- GERN vs MPB Comparison
GERN vs MPB Comparison
Compare GERN & MPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- MPB
- Stock Information
- Founded
- GERN 1990
- MPB 1868
- Country
- GERN United States
- MPB United States
- Employees
- GERN N/A
- MPB N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- MPB Major Banks
- Sector
- GERN Health Care
- MPB Finance
- Exchange
- GERN Nasdaq
- MPB Nasdaq
- Market Cap
- GERN 823.0M
- MPB 675.9M
- IPO Year
- GERN 1996
- MPB N/A
- Fundamental
- Price
- GERN $1.24
- MPB $29.52
- Analyst Decision
- GERN Buy
- MPB Buy
- Analyst Count
- GERN 7
- MPB 2
- Target Price
- GERN $3.17
- MPB $34.50
- AVG Volume (30 Days)
- GERN 7.6M
- MPB 142.3K
- Earning Date
- GERN 11-06-2025
- MPB 10-22-2025
- Dividend Yield
- GERN N/A
- MPB 2.98%
- EPS Growth
- GERN N/A
- MPB N/A
- EPS
- GERN N/A
- MPB 2.41
- Revenue
- GERN $164,447,000.00
- MPB $208,798,000.00
- Revenue This Year
- GERN $172.62
- MPB $25.28
- Revenue Next Year
- GERN $56.87
- MPB $28.41
- P/E Ratio
- GERN N/A
- MPB $12.24
- Revenue Growth
- GERN 11877.20
- MPB 20.40
- 52 Week Low
- GERN $1.09
- MPB $22.50
- 52 Week High
- GERN $4.50
- MPB $33.87
- Technical
- Relative Strength Index (RSI)
- GERN 43.70
- MPB 57.87
- Support Level
- GERN $1.19
- MPB $26.56
- Resistance Level
- GERN $1.31
- MPB $30.00
- Average True Range (ATR)
- GERN 0.07
- MPB 0.78
- MACD
- GERN -0.01
- MPB 0.17
- Stochastic Oscillator
- GERN 17.31
- MPB 83.43
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About MPB Mid Penn Bancorp
Mid Penn Bancorp Inc operates in the financial services domain. It conducts commercial banking and trust business in the United States. Its range of services comprises mortgage and home equity loans, secured and unsecured consists and consumer loans, lines of credit, construction financing, farm loans, community development, local government loans, and various types of time and demand deposits.